Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSage Group Regulatory News (SGE)

Share Price Information for Sage Group (SGE)

Share Price is delayed by 15 minutes
Get Live Data
883.20    30.00 (3.52%)
Bid:
880.60
Ask:
881.40
Spread: 0.80 (0.091%)
Market Cap: £7.96b
SGE Live PriceLast checked at - London Stock Exchange

Intraday Sage Group Share Chart

Director Declaration

24 Mar 2021 09:07

RNS Number : 3186T
Sage Group PLC
24 March 2021
 

 

 

 

 

The Sage Group plc.

24 March 2021

The Sage Group plc. (Sage) announces that Jonathan Howell, Chief Financial Officer of Sage has been appointed as an independent Non-executive Director to the Board of Experian plc, with effect from 1 May 2021.

 

There are no further disclosures required for the purposes of Listing Rule 9.6.14.

 

Enquiries

The Sage Group plc.

 +44 (0) 7900 046714

James Sandford, Investor Relations

Amy Lawson, Media

Vicki Bradin, Company Secretary and General Counsel

 

FTI Consulting 

+44(0) 20 3727 1000

Charles Palmer

Dwight Burden

 

About Sage

Sage (FTSE: SGE) is the global market leader for technology that provides small and medium businesses with the visibility, flexibility and efficiency to manage finances, operations and people. With our partners, Sage is trusted by millions of customers worldwide to deliver the best cloud technology and support. Our years of experience mean that our colleagues and partners understand how to serve our customers and communities through the good, and more challenging times. We are here to help, with practical advice, solutions, expertise and insight.

 

ENDS

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNFIFIAVEISFIL
Date   Source Headline
27th Dec 20245:45 pmRNSTransaction in Own Shares
27th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20245:30 pmRNSTransaction in Own Shares
20th Dec 20245:25 pmRNSTransaction in Own Shares
19th Dec 20246:03 pmRNSDirector/PDMR Shareholding
19th Dec 20245:26 pmRNSTransaction in Own Shares
18th Dec 20245:29 pmRNSTransaction in Own Shares
17th Dec 20246:00 pmRNSTransaction in Own Shares
17th Dec 20244:30 pmRNSDirector/PDMR Shareholding
16th Dec 20249:30 amRNSDirectorate Change
10th Dec 20245:46 pmRNSTransaction in Own Shares
9th Dec 20241:30 pmRNSHolding(s) in Company
6th Dec 20244:30 pmRNSDirector/PDMR Shareholding
6th Dec 202410:45 amRNSBlock listing Interim Review
5th Dec 20246:00 pmRNSDirector/PDMR Shareholding
5th Dec 202411:00 amRNSNotice of AGM
5th Dec 202410:00 amRNSDirector/PDMR Shareholding
5th Dec 202410:00 amRNSDirector/PDMR Shareholding
4th Dec 20245:42 pmRNSTransaction in Own Shares
3rd Dec 20244:30 pmRNSDirector/PDMR Shareholding
3rd Dec 202410:45 amRNSAnnual Financial Report
2nd Dec 20245:45 pmRNSTransaction in Own Shares
29th Nov 20245:50 pmRNSTransaction in Own Shares
29th Nov 20245:50 pmRNSTotal Voting Rights
28th Nov 20245:30 pmRNSTransaction in Own Shares
28th Nov 20242:00 pmRNSDirector/PDMR Shareholding
27th Nov 20245:39 pmRNSTransaction in Own Shares
26th Nov 20245:30 pmRNSTransaction in Own Shares
25th Nov 20246:25 pmRNSDirector/PDMR Shareholding
25th Nov 20246:00 pmRNSTransaction in Own Shares
22nd Nov 20246:14 pmRNSTransaction in Own Shares
22nd Nov 20249:30 amRNSDirector/PDMR Shareholding
21st Nov 20245:39 pmRNSTransaction in Own Shares
20th Nov 20245:51 pmRNSTransaction in Own Shares
20th Nov 20247:00 amRNSResults for the year ended 30 September 2024
20th Nov 20247:00 amRNSSHARE BUYBACK PROGRAMME
31st Oct 20244:00 pmRNSTotal Voting Rights
9th Oct 20243:30 pmRNSHolding(s) in Company
3rd Oct 20242:00 pmRNSDirectorate Change
2nd Oct 202411:11 amRNSDirector/PDMR Shareholding
1st Oct 20245:19 pmRNSTotal Voting Rights
11th Sep 20245:15 pmRNSHolding(s) in Company
11th Sep 20243:30 pmRNSHolding(s) in Company
6th Sep 20243:00 pmRNSDirector Declaration
6th Sep 20243:00 pmRNSHolding(s) in Company
2nd Sep 20245:50 pmRNSTotal Voting Rights
21st Aug 20245:50 pmRNSDirector/PDMR Shareholding
16th Aug 20244:50 pmRNSHolding(s) in Company
7th Aug 20245:46 pmRNSDirector/PDMR Shareholding
6th Aug 20245:38 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.